Chronic treatment with either dexfenfluramine or sibutramine in diet-switched diet-induced obese mice

Endocrine

Volumn 29, Issue 2, 2006, Pages 375-381

  Bush, Eugene N ^a   Shapiro, Robin ^a   Brune, Michael E ^a   Knourek Segel, Victoria E ^a   Droz, Brian A ^a   Fey, Thomas ^a   Lin, Emily ^a   Jacobson, Peer B ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Dexfenfluramine; Diet induced obesity; Sibutramine

Indexed keywords

DEXFENFLURAMINE; GHRELIN; GROWTH HORMONE; INSULIN; LEPTIN; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CALORIC INTAKE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; EPIDIDYMIS FAT; GROWTH HORMONE BLOOD LEVEL; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LIPID DIET; LONG TERM CARE; LOW FAT DIET; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT CONTROL;

EID: 33746216249     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:29:2:375     Document Type: Article

References (28)

1. Hedley, A. A., Ogden, C. L., Johnson, C. L., Carroll, M. D., Curtin, L. R., and Flegal, K. M. (2004). JAMA 291, 2847-2850.
2. Heal, D. J., Aspley, S., Prow, M. R., Jackson, H. C., Martin, K. F., and Cheetham, S. C. (1998). Int. J. Obes. 22(Suppl. 1), S18-S28.
3. Loke, Y. K., Deny, S., and Pritchard-Copley, A. (2002). BMC Clin. Pharmacol. 2, 6.
4. Rothman, R. B., Baumann, M. H., Savage, J. E., et al. (2000). Circulation 102, 2836-2841.
5. Heisler, L. K., Cowley, M. A., Tecott, L. H., et al. (2002). Science 297, 609-611.
6. Parekh, P. I., Petro, A. E., Tiller, J. M., Feinglos, M. N., and Surwit, R. S. (1998). Metabolism 47, 1089-1096.
7. James, W. P., Astrup, A., Finer, N., et al. (2000). Lancet 356(9248), 2119-2125.
8. Levin, B. E. and Dunn-Meynell, A. A. (2000). Am. J. Physiol. Regul. Integ. Comp. Physiol. 279, R2222-2228.
9. Bush, E. N., Droz, B., Shapiro, R., et al. (2003). Endocrine Society 2003 meeting, Abstract P3-97.
10. Weigle, D. S., Cummings, D. E., Newby, P. D., et al. (2003). J. Clin. Endocrinol. Metab. 88, 1577-1586.
11. Tschöp, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E., and Heiman, M. L. (2001). Diabetes 50, 707-709.
12. Dornonville de la Cour, C., Björkqvist, M., Sandvik, A. K., et al. (2001). Regul. Pept. 99, 141-150.
13. Cowley, M. A., Smith, R. G., Diano, S., et al. (2003). Neuron 37, 649-661.
14. Redmon, J. B., Raatz, S. K., Kwong, C. A., Swanson, J. E., Thomas, W., and Bantle, J. P. (1999). Diabetes Care 22, 896-903.
15. Finer, N., Bloom, S. R., Frost, G. S., Banks, L. M., and Griffiths, J. (2000). Diabetes Obes. Metab. 2, 105-112.
16. Iranmanesh, A., Lizarralde, G., and Veldhuis, J. D. (1991). J. Clin. Endocrinol. Metab. 73, 1081-1088.
17. De Marinis, L., Bianchi, A., Mancini, A., et al. (2004). J. Clin. Endocrinol. Metab. 89, 174-180.
18. Drent, M. L., Ader, H. J., and van der Veen, E. A. (1995). J. Endocrinol. Invest. 18, 780-788.
19. Bertherat, J., Bluet-Pajot, M. T., and Epelbaum, J. (1995). Eur. J. Endocrinol. 132, 12-24.
20. Shuto, Y., Shibasaki, T., Otagiri, A., et al. (2002). J. Clin. Invest. 109, 1429-1436.
21. Nakagawa, T., Ukai, K., Ohyama, T., Gomita, Y., and Okamura, H. (2000). Exp. Anim. 49, 239-249.
22. Flint, D. J., Binart, N., Kopchick, J., and Kelly, P. (2003). Pituitary 6, 97-102.
23. Scacchi, M., Ida Pincelli, A., and Cavagnini, F. (2003). Frontiers Neuroendocrinol. 24, 200-224.
24. Nagy, T. R. and Clair, A. L. (2000). Obes. Res. 8, 392-398.
25. Brommage, R. (2003). Am. J. Physiol. Endocrinol. Metab. 285, E454-E459.
26. Künnecke, B., Verry, P., Benardeau, A., and von Kienlin, M. (2004). Obes. Res. 12, 1604-1615.
27. Hancock, A. A., Bennani, Y. L., Bush, E. N., et al. (2004). Eur. J. Pharmacol. 487, 183-197.
28. Day, C. and Bailey, C. J. (1998). Int. J. Obes. Relat. Metab. Disord. 22, 619-623.